Procter & Gamble Health Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹5019.8
- Today's High:
- ₹5144
- Open Price:
- ₹5119.95
- 52W Low:
- ₹3848.8859
- 52W High:
- ₹5496.5
- Prev. Close:
- ₹5076.15
- Volume:
- 832
Company Statistics
- Market Cap.:
- ₹80.97 billion
- Book Value:
- 452.246
- Revenue TTM:
- ₹12.30 billion
- Operating Margin TTM:
- 24.06%
- Gross Profit TTM:
- ₹8.68 billion
- Profit Margin:
- 18.66%
- Return on Assets TTM:
- 18.54%
- Return on Equity TTM:
- 33.56%
Company Profile
Procter & Gamble Health Limited had its IPO on under the ticker symbol PGHL.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Procter & Gamble Health Limited has a staff strength of 0 employees.
Stock update
Shares of Procter & Gamble Health Limited opened at ₹5119.95 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹5019.8 - ₹5144, and closed at ₹5098.
This is a +0.43% increase from the previous day's closing price.
A total volume of 832 shares were traded at the close of the day’s session.
In the last one week, shares of Procter & Gamble Health Limited have increased by +1.87%.
Procter & Gamble Health Limited's Key Ratios
Procter & Gamble Health Limited has a market cap of ₹80.97 billion, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months Procter & Gamble Health Limited’s revenue was ₹12.30 billion with a gross profit of ₹8.68 billion and an EBITDA of ₹3.24 billion. The EBITDA ratio measures Procter & Gamble Health Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Procter & Gamble Health Limited’s operating margin was 24.06% while its return on assets stood at 18.54% with a return of equity of 33.56%.
In Q2, Procter & Gamble Health Limited’s quarterly earnings growth was a negative -27.5% while revenue growth was a positive 1.8%.
Procter & Gamble Health Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 34.9034
- PEG
Its diluted EPS in the last 12-months stands at ₹139.76 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Procter & Gamble Health Limited’s profitability.
Procter & Gamble Health Limited stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
Procter & Gamble Health Limited stock pays annual dividends of ₹95 per share, indicating a yield of 1.96% and a payout ratio of 46.98%.
Balance sheet and cash flow metrics
- Total Assets
- ₹11.01 billion
- Total Liabilities
- ₹3.04 billion
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 46.98%
Procter & Gamble Health Limited ended 2024 with ₹11.01 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹11.01 billion while shareholder equity stood at ₹7.51 billion.
Procter & Gamble Health Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹3.04 billion in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹4.35 billion and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.
Procter & Gamble Health Limited’s total current assets stands at ₹7.96 billion while long-term investments were ₹0 and short-term investments were ₹177.30 million. Its net receivables were ₹1.16 billion compared to accounts payable of ₹2.37 billion and inventory worth ₹1.35 billion.
In 2024, Procter & Gamble Health Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Procter & Gamble Health Limited paid ₹0.47 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹5098
- 52-Week High
- ₹5496.5
- 52-Week Low
- ₹3848.8859
- Analyst Target Price
- ₹
Procter & Gamble Health Limited stock is currently trading at ₹5098 per share. It touched a 52-week high of ₹5496.5 and a 52-week low of ₹5496.5. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹5166.93 and 200-day moving average was ₹4747.76 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 5214.9% of the company’s stock are held by insiders while 1403.9% are held by institutions.
Frequently Asked Questions About Procter & Gamble Health Limited
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Most Active
Top Gainers
Top Losers
About
Procter & Gamble Health Limited manufactures and markets pharmaceuticals and chemical products in India and internationally. It provides over-the-counter products, vitamins, minerals, and supplements. The company offers its products under the Cosome, Polybion, Neurobion, Evion, Nasivion, Livogen, and Seven Seas brands. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. The company was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble Health Limited is a subsidiary of Procter & Gamble Overseas India BV.